For instance, the ancillary study of the Diabetes Control and Complications Trial (DCCT) revealed that intensive insulin therapy in T1D was associated with profound weight gain, increasing body mass index (BMI), especially in the top quartile, blood pressure, and adverse lipid profiles [13]. This evidence concerns the gene INS and diabetes mellitus.